"Chromogenic Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens).
Descriptor ID |
D002863
|
MeSH Number(s) |
D27.720.233.174 D27.720.470.410.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chromogenic Compounds".
Below are MeSH descriptors whose meaning is more specific than "Chromogenic Compounds".
This graph shows the total number of publications written about "Chromogenic Compounds" by people in this website by year, and whether "Chromogenic Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chromogenic Compounds" by people in Profiles.
-
Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol. 2013 Sep; 51(9):3097-101.
-
Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. J Clin Microbiol. 2012 Aug; 50(8):2596-600.
-
MYC amplification in breast cancer: a chromogenic in situ hybridisation study. J Clin Pathol. 2007 Sep; 60(9):1017-23.
-
Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritis. Arthritis Rheum. 1984 Oct; 27(10):1122-9.